“Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects With Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s47, https://doi.org/10.25251/skin.5.supp.47.